US Patent Issued to Olfactive Ai on May 6 for "Compositions and methods for treating endocrine diseases and disorders" (California, New York Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,550, issued on May 6, was assigned to Olfactive Ai Inc. (Mountain View, Calif.).

"Compositions and methods for treating endocrine diseases and disorders" was invented by Christopher Hanson (Mountain View, Calif.) and William Harries (Colden, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion."

The patent was file...